Results 71 to 80 of about 896 (121)

Efficacy and safety of gestogens in women with metabolic syndrome [PDF]

Гинекология, 2014
The paper presents a study of the safety and effectiveness of gestogen support of pregnancy in patients with metabolic syndrome. Efficacy of dydrogesterone in the development of the threat of termination in the first trimester has been demonstrated in 91%
E I Borovkova
doaj  

DMAP1 Deficiency Suppresses Lung Cancer Progression by Destabilizing Replication Fork and Activating IFN Signaling‐Mediated Anti‐tumor Immunity

Advanced Science, Volume 13, Issue 33, 15 June 2026.
Lung cancer remains the leading cause of cancer‐related death. We investigated the role of the epigenetic regulator DMAP1 in NSCLC and found that its loss induces replication stress and DNA damage. This in turn activates type I IFN signaling via the cGAS–STING pathway and transcriptional ISG de‐repression, enhancing anti‐tumor immune responses ...
Kan Huang, Xi Dai, Shuaihu Li, Yingxue Chen, Yaxin Yu, Lin Wang, Kun Liu, Shuhan Lyu, Chongyang Li, Yihua Sun, Fei Li   +10 more
wiley   +1 more source

Effect of Dydrogesterone on Treatment of Threatened Miscarriage: A Systematic Review and Meta-Analyses

Thai Journal of Obstetrics and Gynaecology, 2011
Objectives: We performed a systematic review and meta-analyses to assess the benefits and adverse effects of Dydrogesterone orally in treatment women with threatened miscarriage.
Thitiporn Siriwachirachai, Thammasorn Piriyasupong   +1 more
doaj  

Predicting live birth following single euploid frozen‐embryo transfer via β‐hCG dynamics: iHOPE prognostic model with external validation

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 6, Page 824-835, June 2026.
ABSTRACT Objectives To determine the prognostic value of serum β‐human chorionic gonadotropin (β‐hCG) for predicting live birth following single euploid frozen‐embryo transfer (FET), and to develop and validate a prognostic model (iHOPE) for this purpose. Methods This retrospective cohort study used data from two large fertility practices.
E. Kalafat, B. Ata, R. Del Gallego, A. Freedman, L. R. Hoyos, I. Elkhatib, K. A. Miller, H. Fatemi, B. Lawrenz   +8 more
wiley   +1 more source

Immunomodulatory Role of Natural Progesterone in Pregnancy: A Review

Journal of Obstetrics and Gynaecology Research, Volume 52, Issue 6, June 2026.
ABSTRACT Aim Pregnancy complications such as miscarriage, preterm birth (PTB), and luteal phase defects (LPD) are significant reproductive health issues globally, with both physical and psychological implications. This review aims to examine the role of natural progesterone in pregnancy‐related disorders, specifically threatened and recurrent ...
Prakash Mehta, Hemant Deshpande, Anjali Deshpande, Reshma Quadros, Shruti Dharmadhikari, Chintan Khandhedia, Gaurav Puppalwar, Amey Mane, Suyog Mehta   +8 more
wiley   +1 more source

Efficacy and safety of estradiol/dydrogesterone combined with escitalopram in the treatment of anxiety and depression in perimenopausal women: a randomized controlled trial

Frontiers in Physiology
BackgroundTo investigate the efficacy and underlying mechanisms of a combined therapy of estradiol/dydrogesterone and escitalopram in treating perimenopausal anxiety and depression.MethodsA total of 195 patients were randomized to receive escitalopram ...
Shufang Wu, Shufang Wu, Shufang Wu, Shufang Wu, Guiying Zeng, Guiying Zeng, Guiying Zeng, Guiying Zeng, Saisai Chen, Saisai Chen, Saisai Chen, Saisai Chen, Hongbin Chen, Hongbin Chen, Hongbin Chen, Hongbin Chen, Senpei Xie, Senpei Xie, Senpei Xie, Senpei Xie, Jiabao Zhang, Jiabao Zhang, Jiabao Zhang, Jiabao Zhang, Yingchun Xiao, Yingchun Xiao, Yingchun Xiao, Yingchun Xiao, Nan Liu, Nan Liu, Nan Liu, Nan Liu, Hui Chen, Ronghua Chen, Ronghua Chen, Ronghua Chen, Ronghua Chen   +36 more
doaj   +1 more source

Dydrogesterone use in recurrent pregnancy loss and luteal phase insufficiency: a knowledge, attitude, and practice survey amongst Indian obstetricians and gynaecologists [PDF]

Background: Oral dydrogesterone is effective in treating reproductive disorders such as recurrent pregnancy loss (RPL) and is a better option than progesterone for luteal phase support (LPS) after in-vitro fertilization (IVF).
Gundu, Shridevi, Vyas, Lila, Chandra, Sunita, Mittal, Pratima, Tank, Jaydeep, Suryawanshi, Sachin, Mukhopadhyay, Ashish Kumar, Tandulwadkar, Sunita, Gupte, Sanjay, Bapat, Kawita, Bhat, Vidya, Mahapatra, Purna Chandra, Batra, Achla, Tank, Parikshit, Kulkarni, Ketan, Reddy, Jayanthi, Gupta, Mahesh   +16 more
core   +1 more source

Dydrogesterone versus levonorgestrel-releasing intrauterine system for abnormal uterine bleeding: a propensity score-matched analysis of long-term efficacy and recurrence

Gynecological Endocrinology
Objective To compare dydrogesterone versus levonorgestrel-releasing intrauterine system (LNG-IUS) for abnormal uterine bleeding (AUB) management with long-term follow-up and etiology-stratified analysis.Methods This single-center retrospective cohort ...
Xiaoli Wei, Li Huang, Xiangzun Li
doaj   +1 more source

Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in China

, 2021
This study aimed to evaluate the efficacy and safety of ultra-low-dose estradiol plus dydrogesterone for vasomotor symptoms in postmenopausal women in China (trial registration CTR20160689).
C. Pexman-Fieth (11283500), L. Gu (4279336), X. Ruan (2568316), M. Ren (4805232), E. Kahler (11283503), Q. Yu (5532347)   +5 more
core   +1 more source

Analysis of Medroxyprogesterone Acetate and Dydrogesterone Effects on Rat Endometrium

, 2000
Amaç: Rat endometriumunda medroksiprogesteron asetat ve dydrogesteronun etkilerini karşılaştırmak. Yöntem: 28 adet Wistar cinsi dişi rat kullanıldı. Ratlar 3 gruba ayrıldı.
Acar, Ali, Bala, Ayfer, Kaymakçı, Mine, Çapar, Metin, Akyürek, Cemalettin   +4 more
core